Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs

• Published in: Bioconjugate chemistry 2017-04, Vol.28 (4), p.857-868
• Main Authors: Fouladi, Farnaz, Steffen, Kristine J, Mallik, Sanku
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic Agents - administration & dosage; Antineoplastic drugs; Antitumor agents; Biocatalysis; Cargo; Cathepsin B - metabolism; Cellular structure; Delayed-Action Preparations - chemistry; Delayed-Action Preparations - metabolism; Destabilization; Drug delivery; Drug delivery systems; Drug Delivery Systems - methods; Enzymes; Humans; Ligands; Lipids; Lipopeptides - chemistry; Lipopeptides - metabolism; Liposomes; Liposomes - chemistry; Liposomes - metabolism; Matrix Metalloproteinases - metabolism; Neoplasms - drug therapy; Pancreatic Elastase - metabolism; Payloads; Peptides; Phospholipases A2, Secretory - metabolism; Polymers; Polymers - chemistry; Polymers - metabolism; Prodrugs - administration & dosage; Prostate-Specific Antigen - metabolism; Stimuli; Tissues; Urokinase-Type Plasminogen Activator - metabolism
• ISSN: 1043-1802; 1520-4812
• DOI: 10.1021/acs.bioconjchem.6b00736

Liposomes are nanocarriers that deliver the payloads at the target site, leading to therapeutic drug concentrations at the diseased site and reduced toxic effects in healthy tissues. Several approaches have been used to enhance the ability of the nanocarrier to target the specific tissues, including ligand-targeted liposomes and stimuli-responsive liposomes. Ligand-targeted liposomes exhibit higher uptake by the target tissue due to the targeting ligand attached to the surface, while the stimuli-responsive liposomes do not release their cargo unless they expose to an endogenous or exogenous stimulant at the target site. In this review, we mainly focus on the liposomes that are responsive to pathologically increased levels of enzymes at the target site. Enzyme-responsive liposomes release their cargo upon contact with the enzyme through several destabilization mechanisms: (1) structural perturbation in the lipid bilayer, (2) removal of a shielding polymer from the surface and increased cellular uptake, (3) cleavage of a lipopeptide or lipopolymer incorporated in the bilayer, and (4) activation of a prodrug in the liposomes.